# Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.

> **NCT07247942** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 8 (actual)

## Conditions studied

- Healthy Subjects (HS)

## Interventions

- **DRUG:** zidebactam administered as a 1g (approximately 200 μCi) IV infusion over 1 hour

## Key facts

- **NCT ID:** NCT07247942
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-13
- **Primary completion:** 2018-01-20
- **Final completion:** 2019-01-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07247942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07247942, "Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07247942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*